GLAZER CAPITAL, LLC - EUCRATES BIOMEDICAL ACQU COR ownership

Back to all holdings Add to watchlist

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 40 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
GLAZER CAPITAL, LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q3 2022$10,245,000
+218.0%
1,022,411
+213.8%
0.19%
+135.0%
Q2 2022$3,222,000
+388.9%
325,806
+386.5%
0.08%
+344.4%
Q1 2022$659,000
+0.8%
66,965
-0.0%
0.02%
+12.5%
Q4 2021$654,000–66,990–0.02%–
 Download
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q1 2022
NameSharesValueWeighting ↓
SkyView Investment Advisors, LLC 71,773$7170.22%
EcoR1 Capital, LLC 200,000$1,998,0000.06%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 3,483$34,7950.00%
Tower Research Capital LLC (TRC) 657$70.00%
DEUTSCHE BANK AG\ 21,923$219,0110.00%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders